PPN Expands Influence in Pharmacy Media with New Hosting Platform and June Podcast Lineup
Pharmacy Podcast Network Unveils New Host Membership & Analytics Platform, Announces Four New Podcast Launches for June
BROWNSVILLE, PA / ACCESS Newswire / May 21, 2025 / The Pharmacy Podcast Network (PPN), the world's largest podcast network dedicated to the profession of pharmacy, proudly announces the launch of a Podcast Hosting Membership and Metrics Platform designed by JB Consulting, a custom healthcare software firm, to empower pharmacy podcast creators with cutting-edge tools, insights, and growth opportunities. This expansion comes alongside the announcement of four new podcasts premiering in June, continuing PPN's mission to elevate authentic and informative healthcare conversations.
Returning by popular demand, the subject of mental health is at the forefront of healthcare. The PPN is excited to announce the new podcast called MindBridge: A Behavioral Health Podcast, hosted by Dr. Ryan Paul Liabenow, PhD, CEO of Mango Health. Focused on mental health and best practices in behavioral-assisted treatments, MindBridge brings critical dialogue to pharmacists and healthcare providers at the forefront of behavioral medicine.
The Executive Dose is another new addition to the Pharmacy Podcast Network, hosted by Stephen Beckman, CEO of YARAL Pharma. This no-fluff, C-suite-level podcast digs into the real-world pressures-and possibilities-reshaping the pharmaceutical industry. Expect sharp insights, straight talk, and stories that hit home for today's pharmacy professionals. 'Pharma, like pharmacy care, is at a tipping point,' said Beckman. 'With 145 million podcast listeners in the U.S., PPN cuts through the noise and delivers what matters to the pharmacy business community. YARAL Pharma is proud to fuel the conversation on this powerful platform.'
The PBM Reform Podcast, originally launched in 2019, returns with new host Greg Reybold, Vice President of Healthcare Policy and General Counsel at American Pharmacy Cooperative, Inc. (APCI). Greg is a veteran healthcare attorney and government affairs professional who has been immersed in PBM reform at the state and federal level for years. His work in the PBM reform arena includes drafting several first-in-the-nation bills which have served as the basis for model legislation throughout the nation.
RxSafe Eyecon is back with a special limited series titled Building Your LTC Pharmacy at Home Business. This critical series explores how independent pharmacies can enter the booming 'LTC-at-Home' market, combatting the rise of pharmacy deserts caused by closures in 2025 and offering a new revenue stream tied to patient access and public health.
'Podcasting has been present in pharmacy because of the PPN,' said Todd Eury, Founder and Editor-in-Chief of the Pharmacy Podcast Network. 'It's a platform built for providers, pharmacy owners, and healthcare insiders since 2009. We're growing with our Host Membership Platform, building new shows, and attracting new talent from pharmacists and thought leaders globally.'
Tonight, PPN will host its 2025 Host Membership Meeting at 7:00 p.m. ET, bringing together over 30 current hosts and welcoming new voices to the network. Special guest John Nosta, internationally recognized AI health philosopher and CEO of NostaLab, will keynote the event.
'The future of healthcare is not just data-driven-it's voice-driven. Podcasting provides the authentic interface where ideas meet innovation,' said John Nosta.
PPN is also launching a new metrics system, enabling hosts and clients to track podcast downloads, episode performance, and listener demographics with more granularity and transparency-empowering better content and business development decisions.
ABOUT PHARMACY PODCAST NETWORK
Founded in 2009, the Pharmacy Podcast Network is the leading podcast media company for the global pharmacy profession, with over 80,000 monthly listeners across 40+ active shows. PPN delivers content focused on business, clinical care, innovation, advocacy, and policy in pharmacy.\
ABOUT YARAL PHARMA
YARAL Pharma, the US generics subsidiary of the multinational pharmaceutical company IBSA, manufactures and markets generic medicines across a range of therapeutic areas including pain and endocrinology. YARAL is committed to improving access to high-quality, authorized and complex generic medications.
ABOUT MANGO HEALTH
Mango Health is a micro-pharmacy platform tailored for behavioral health settings, specializing in psychiatric medication management, medication-assisted treatment (MAT), sexual health, and drug-related infectious disease care.
ABOUT AMERICAN PHARMACY COOPERATIVE, INC. (APCI)
Since 1984, APCI has served independent community pharmacies across the nation with group purchasing, advocacy, and a wide range of industry-leading pharmacy services. The co-op is headquartered in Bessemer, Ala.
About Eyecon | RxSafe
Eyecon | RxSafe is transforming the pharmacy industry through advanced automation technologies that drive efficiency, accuracy, and patient safety. Together, we empower pharmacies with cutting-edge tools that streamline operations, elevate patient care, and ensure long-term success. From visual precision counting to high-volume adherence packaging, our solutions are built to support today's pharmacy challenges and tomorrow's growth. Empowering Pharmacies Through Innovation.
ABOUT NOSTALAB
NostaLab is a health innovation think tank led by John Nosta, a globally recognized thought leader exploring the intersection of digital health, artificial intelligence, and future medicine.
Media Contact:
Todd Eury
CEO
[email protected]
(412) 585-4001
RxPR.net
SOURCE: Pharmacy Podcast Network
press release
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
Louisiana attorney general investigates CVS over mass texts about pharmacy bill
LOUISIANA () — This week, CVS customers across Louisiana were met with an alarming text message: 'Last-minute legislation in Louisiana threatens to close your CVS Pharmacy—your medication cost may go up and your pharmacist may lose their job. Contact your elected officials to protect your access.' The text, which quickly triggered confusion and concern, refers to House Bill 358—a late-session proposal that would ban pharmacy benefit managers (PBMs) like CVS Caremark from owning or controlling pharmacies in the state. Critics of the message say it's more than a warning; it's a political campaign that may have crossed a legal line. Close Thanks for signing up! Watch for us in your inbox. Subscribe Now 'People give their information to health care providers to provide patient information for the betterment of their health,' said former state senator and pharmacist Fred Mills. 'I don't know if they give this information for political purposes.' PBMs act as a middleman between insurance companies, drug manufacturers and pharmacies. Supporters of the bill argue that this dual role (particularly when companies like CVS own both the PBM and the pharmacy) creates a conflict of interest and limits consumer choice. 'If you work for a company that decides you'll pay $5 or $10 for your prescriptions, the PBM implements that plan,' Mills said. 'So, they're kind of like a Visa Card for prescriptions.' But Louisiana Attorney General Liz Murrill says CVS went too far by using private customer data for lobbying. Federal investigation underway into allegedly undocumented LCG workers 'They were sending out information using people's personal cell phone numbers to lobby against legislation that they didn't like,' Murrill said. 'That is not the purpose for which they obtained our personal information.' In response, Murrill says her office has issued a cease-and-desist letter and opened an investigation into whether CVS violated the state's Unfair Trade Practices Act. 'CVS has cornered the market and used that market to run a lot of independent pharmacists out of business,' she said. 'It's also running up our costs of medication.' In a public statement, CVS claimed the legislation would force the company to close 119 pharmacies in Louisiana, impacting one million patients and nearly 2,700 employees. But Murrill and other state officials argue the company's messaging is misleading. 'The loss of independent pharmacies has been much more damaging to us than losing a large chain pharmacy like CVS,' Murrill said. 'It is so damaging to our rural communities. And they have been decidedly persistent in putting them out of business.' The bill did not pass despite pressure from Governor Landry. If Governor Landry does call a special session, it would most likely happen in August. Louisiana attorney general investigates CVS over mass texts about pharmacy bill Rubio: US 'not involved' in Israel's strike inside Iran Teacher accused of giving Denver middle school students cannabis brownies Israel attacks Iran's capital with explosions booming across Tehran 'It was still chasing her': 9-year-old girl attacked by shark while swimming at Florida beach Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
4 hours ago
- Yahoo
Louisiana lawmakers push for transparency in drug pricing, bill advances
BATON ROUGE, La. (Louisiana First) — A bill aimed at regulating pharmacy benefit managers (PBMs) has passed and is awaiting the governor's signature. HB 264, authored by Michael Echols (R-La.), is geared towards ensuring fair reimbursement and transparency in drug pricing. The bill redefines the term rebate, which would include a wide range of discounts received by PBMs. These changes are meant to highlight how PBMs negotiate and profit from deals with drug manufacturers. It would also allow PBMs to label certain submitted information as confidential. The Commissioner of Insurance would have the authority to review PBM records and compensation structures and ensure reasonable reimbursements. Donald Trump Jr. took to social media, asking Louisiana to pass HB 358, which would allow a pharmacy technician to work remotely in certain circumstances. 'It's time to pass HB358 and end the charade that costs hard-working Americans so much money when buying prescription drugs. Enough is Enough!' Trump wrote. EBR Metro Council picks new advisor for Raising Canes River Center redevelopment project 'It's a big problem in Baton Rouge': Authorities suspect human trafficking in massage parlors College Drive flyover project complete, brings relief to Baton Rouge drivers Louisiana lawmakers push for transparency in drug pricing, bill advances Judge blocks Trump's National Guard deployment in Los Angeles Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
3 days ago
- Yahoo
PBM lobby sues Arkansas over law requiring drug middlemen to sell pharmacies
This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. The main lobby representing pharmacy benefit managers is suing Arkansas in a bid to stop the state's law preventing the drug middlemen from owning pharmacies. The Pharmaceutical Care Management Association's lawsuit filed Monday in a federal court argues that Arkansas' law — the first of its kind — is unconstitutional and would result in pharmacies closing and medications becoming more difficult for Arkansans to access. It's the latest legal challenge from the PBM industry as it hustles to halt the law and set a precedent that might dissuade other states from passing similar legislation. Arkansas' legislation, called Act 624, is meant to protect local community pharmacies from larger, more diversified chains by requiring companies that own both PBMs and pharmacies to shutter their operations in the state. When signing Act 624 in April, Gov. Sarah Huckabee Sanders said the law was necessary to curb anticompetitive behavior among major PBMs that threatens Arkansas' independent pharmacies. However, PBMs — powerful middlemen that shape interactions and payments between drugmakers, payers and pharmacies — decried the law, arguing it eliminates a significant source of efficiency in the pharmacy supply chain by forcing them to sell off their brick-and-mortar stores and halt mail-order pharmacy operations in the state. The policy would unfairly benefit Arkansas-owned pharmacies at their expense, major PBMs said. Now, the PCMA — which represents 20 PBMs, including the so-called 'Big Three' that control an outsized share of the market — is taking to the courts in an attempt to stop the law before it kicks in at the start of 2026. Arkansas' law will cause roughly 40 PBM-owned pharmacies to close, along with eliminating home delivery options and jeopardizing access to specialty drugs for patients managing complex conditions, according to the PCMA's complaint. Act 624 will also lead to job losses and reduce market competition, which could cause costs to to rise for patients and their payers, the association argues. 'We will continue to fight to protect patients' access to health care and educate policymakers and stakeholders about the severe consequences of harmful legislation threatening patient access to pharmacy services,' the PCMA said in an emailed statement. The lobby's lawsuit argues that Act 624 violates the Constitution's Dormant Commerce clause and Privileges and Immunities clause by penalizing out-of-state operators to protect local businesses. The law also violates the Bill of Attainder clause, which forbids states from enacting punishments — in this case, revoking an actor's permit to conduct business — without a court proceeding, according to the complaint. The complaint makes similar legal arguments as prior lawsuits filed against Arkansas' law by CVS and Cigna, which operate two of the largest PBMs in the country: Caremark and Express Scripts, respectively. 'PCMA does not bring this suit because Act 624 is bad policy, although it very certainly is. Rather PCMA brings this suit because Act 624 is as clear an example of unconstitutional state legislation as the Court is likely ever to see,' the complaint reads. The PCMA's suit, which was filed in Arkansas' eastern district against the state's pharmacy board, seeks a preliminary injunction barring enforcement of the law while the lawsuit proceeds. Navitus Health Solutions is also a plaintiff in the suit. The Wisconsin-based PBM, which operates on a pass-through model — meaning it makes money only through administrative fees and not by retaining rebates — is not a member of the PCMA. The outcome of the suits could have significant ramifications for the PBM industry, as other states considering similar legislation could be deterred or spurred on by the court's eventual decision. Bills with similar provisions were recently introduced in Vermont, Texas and New York. States are stepping into a gap left by Congress as lawmakers scramble to make prescription drugs more affordable. Despite numerous proposals to rein in controversial PBM business practices over the past few years — including a bill that would force PBMs to sell pharmacy businesses nationwide — Congress has yet to pass significant federal reform. However, lawmakers on both sides of the aisle in Washington have expressed anger over PBMs' business practices in recent hearings. And, the GOP megabill currently being considered by the Senate includes some PBM provisions, including banning spread pricing in Medicaid, preventing PBMs from being paid based on a drug's list price and requiring more transparency about PBMs' business practices. Recommended Reading CVS, Cigna sue Arkansas to overturn new PBM law
